Avatrombopag maleate (AVAT), a second-generation oral
thrombopoietin
(TPO) receptor agonist, is currently in development for the therapeutic
management of thrombocytopenia. The present study introduces a novel
comparative analysis that elucidates the intricate relationship between
the crystallographic structures and the diverse physicochemical properties
inherent to the complex polymorphic forms of the Avatrombopag (AVA)
maleic salt. Seven solid-state forms, including two polymorphic forms
(AVAT-B, AVAT-C), a new trihydrate (AVAT-3H), and four solvates (AVAT-A,
AVAT-dimethyl sulfoxide (AVAT-DMSO), AVAT-dimethylformamide (AVAT-DMF),
and AVAT-tetrahydrofuran (AVAT-THF)), were synthesized and analyzed
in detail. Although the powder diffraction patterns for polymorphs
AVAT-A, AVAT-B, and AVAT-C have been previously reported, our study
marks the inaugural report of their crystallographic structures. Trihydrate
and three new solvates were initially identified and subjected to
a comprehensive characterization through thermal analysis, X-ray diffraction,
etc. Thermal stability and transformation in aqueous solutions for
different forms were conducted. Surprisingly, it was found that all
five other solid forms except AVAT-B would be transformed to AVAT-3H
when suspended in aqueous solution. All solvates retained their original
framework structure after the removal of part of the solvent and could
not lose all solvents until decomposition. AVAT trihydrate did not
lose water upon storage under ambient conditions. Furthermore, the
solubility profiles of AVAT-B, AVAT-C, and AVAT-3H were meticulously
determined. By integrating the distinct molecular conformations with
the respective intermolecular and intramolecular interactions as well
as the packing arrangements, we were able to elucidate the underlying
factors influencing their phase behavior. The insights gained from
this analysis were instrumental in simulating crystal growth, thereby
facilitating a comprehensive understanding of the specific interactions
that govern the phase behavior of these compounds.